Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00256620 · ClinicalTrials.gov registry record · NA
Improving Outcomes and Quality of Life After CABG
A NA study of Coronary Artery Bypass Graft Surgery Patients, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- NA
- Development phase
- 412
- Enrollment target
- 1
- Study location
NCT00256620: Completed NA study of Coronary Artery Bypass Graft Surgery Patients, sponsored by Weill Medical College of Cornell University.
NCT00256620 is a NA study of Coronary Artery Bypass Graft Surgery Patients that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 412 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00256620, a NA study of Coronary Artery Bypass Graft Surgery Patients, has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- NA
- Development phase
- 412 participants
- Enrollment target
- 1
- Study location
Study Summary
The principal objective to this randomized trial is to compare the efficacy of two strategies of intra-operative hemodynamic management during cardiopulmonary bypass among patients undergoing primary elective coronary artery bypass graft (CABG) surgery in preventing peri-operative cardiac, cognitive and neurologic morbidity and mortality and post-operative deterioration in the patient's quality of life as measured by the seven domains of SF-36 Health Survey (bodily pain, health perceptions, energy, and mental, physical, social and role function).
Conditions Studied
Interventions
- PROCEDURE Mean arterial pressure during cardiopulmonary bypass 80 mmHg vs. customized
Study Locations (1)
New York
- New York Presbyterian Hospital-Weill Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 412 participants |
| Start Date | 1996-12 |
| Est. Completion | 1999-12 |
| Phase | NA |
What the finished NCT00256620 record still lists
NCT00256620 is an interventional study that assigns participants to a tested intervention. The registered 412 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (71% lower).
The record links to 1 condition, with Coronary Artery Bypass Graft Surgery Patients appearing as the primary indexed condition, and to 1 intervention - of which Mean arterial pressure during cardiopulmonary bypass 80 mmHg vs. customized is the first listed.
NCT00256620 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT00256620 about?
NCT00256620 is a clinical study titled "Improving Outcomes and Quality of Life After CABG". The principal objective to this randomized trial is to compare the efficacy of two strategies of intra-operative hemodynamic management during cardiopulmonary bypass among patients undergoing primary elective coronary artery bypass graft (CABG) surgery in preventing peri-operative cardiac, cognitive...
What is the current status of trial NCT00256620?
This trial is currently completed. It is a NA study. The enrollment target is 412 participants. The study started on 1996-12. Estimated completion is 1999-12.
What conditions does trial NCT00256620 study?
This clinical trial studies the following conditions: Coronary Artery Bypass Graft Surgery Patients.
What interventions are being tested in trial NCT00256620?
The interventions under investigation include: Mean arterial pressure during cardiopulmonary bypass 80 mmHg vs. customized (PROCEDURE).
Who is sponsoring clinical trial NCT00256620?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00256620 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00256620's enrollment target sits among peer trials
412 241st of 2000 higher than 1,759 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05993689 · 412 participants · NA
Building TrUst and UNiting Teams Through DouLa partnErship - BUNDLE
- NCT06699212 · 412 participants · Phase 3
A Study of ASP-1929 Photoimmunotherapy in Combination With Pembrolizumab in First-line Treatment of Locoregional Recurrent Squamous Cell Carcinoma of the Head and Neck With No Distant Metastases
- NCT03592472 · 413 participants · Phase 3
A Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV)
- NCT06697197 · 413 participants · Phase 1
A Study of BMS-986482 Alone or as Combination Therapy in Participants With Advanced Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia